• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大容量无细胞浓缩腹水回输疗法可改善肝硬化患者的静脉血流。

Large-volume cell-free and concentrated ascites reinfusion therapy improves venous flow in patients with liver cirrhosis.

作者信息

Matsumoto Naoki, Ogawa Masahiro, Kanda Tatsuo, Matsuoka Shunichi, Moriyama Mitsuhiko, Matsusaki Keisuke

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi Kamimachi, Itabashi-ku, Tokyo, 173-8610, Japan.

Ascites Treatment Center, Kanamecho Hospital, 1-11-13 Kanamecho, Toshima-ku, Tokyo, 171-0043, Japan.

出版信息

J Med Ultrason (2001). 2021 Jul;48(3):315-322. doi: 10.1007/s10396-021-01094-2. Epub 2021 Apr 9.

DOI:10.1007/s10396-021-01094-2
PMID:33835337
Abstract

PURPOSE

Hemodynamic change after total paracentesis was investigated because it might lead to various complications. Although cell-free and concentrated ascites reinfusion therapy (CART) is safer and more effective than total paracentesis in theory, hemodynamic change after CART has been never reported. And previous studies did not mention hemodynamics of the venous system.

METHODS

We investigated the hemodynamic change, including that of the venous system, before and after CART using color Doppler ultrasonography and fast Fourier transform analysis. Twenty-eight patients with tensive cirrhotic ascites underwent ultrasonography the day before and after total volume CART. The diameter and velocity of the main, right, and left portal vein; inferior vena cava (IVC); and right renal vein were measured using ultrasonography.

RESULTS

A total of 11.8 ± 4.4 L of ascites (range 3.6-20.9 L) was filtered and concentrated to 0.85 ± 0.40 L (range 0.36-1.50 L). The diameter of the IVC increased from median 13.5 ± 5.4 mm (range 4-25 mm) to 18.5 ± 4.1 mm (range 7-29 mm) (p = 0.007). The diameter of the right segmental renal vein significantly increased after KM-CART [from 5.0 ± 1.0 (4-8) mm to 7.0 ± 2.0 (3-10) mm] (p = 0.011). Hemodynamic change of the portal venous system was not significant. The time to the next CART in patients with an IVC diameter ≥ 20 mm and < 20 mm was 86 days and 20.5 days (p = 0.035), respectively.

CONCLUSION

Tensive ascites results in venous congestion in patients with cirrhotic ascites. CART improved venous flow, but it did not change the hemodynamics of the portal venous system.

摘要

目的

研究大量腹腔穿刺放液后的血流动力学变化,因为其可能导致各种并发症。尽管理论上无细胞浓缩腹水回输疗法(CART)比大量腹腔穿刺放液更安全、更有效,但此前从未有关于CART后血流动力学变化的报道。而且既往研究未提及静脉系统的血流动力学情况。

方法

我们使用彩色多普勒超声和快速傅里叶变换分析,研究了CART前后的血流动力学变化,包括静脉系统的变化。28例肝硬化张力性腹水患者在进行全量CART的前一天和后一天接受了超声检查。使用超声测量门静脉主干、右支和左支、下腔静脉(IVC)以及右肾静脉的直径和流速。

结果

共过滤并浓缩了11.8±4.4L腹水(范围3.6 - 20.9L)至0.85±0.40L(范围0.36 - 1.50L)。IVC直径从中位数13.5±5.4mm(范围4 - 25mm)增加至18.5±4.1mm(范围7 - 29mm)(p = 0.007)。右段肾静脉直径在KM - CART后显著增加[从5.0±1.0(4 - 8)mm增加至7.0±2.0(3 - 10)mm](p = 0.011)。门静脉系统的血流动力学变化不显著。IVC直径≥20mm和<20mm的患者下次进行CART的时间分别为86天和20.5天(p = 0.035)。

结论

肝硬化腹水患者的张力性腹水导致静脉淤血。CART改善了静脉血流,但未改变门静脉系统的血流动力学。

相似文献

1
Large-volume cell-free and concentrated ascites reinfusion therapy improves venous flow in patients with liver cirrhosis.大容量无细胞浓缩腹水回输疗法可改善肝硬化患者的静脉血流。
J Med Ultrason (2001). 2021 Jul;48(3):315-322. doi: 10.1007/s10396-021-01094-2. Epub 2021 Apr 9.
2
Renal vein measurement using ultrasonography in patients with cirrhotic ascites and congestive heart failure.超声测量肝硬化腹水并充血性心力衰竭患者的肾静脉。
J Med Ultrason (2001). 2021 Apr;48(2):225-234. doi: 10.1007/s10396-021-01088-0. Epub 2021 Mar 25.
3
Portal hemodynamics after large-volume paracentesis in patients with liver cirrhosis and tense ascites.
Dig Dis Sci. 1998 Nov;43(11):2470-2. doi: 10.1023/a:1026638316826.
4
Safety and efficacy of cell-free and concentrated ascites reinfusion therapy against cirrhotic ascites in comparison with malignancy-related ascites.与恶性肿瘤相关腹水相比,无细胞浓缩腹水回输疗法治疗肝硬化腹水的安全性和有效性。
J Gastroenterol Hepatol. 2021 Nov;36(11):3224-3232. doi: 10.1111/jgh.15620. Epub 2021 Aug 22.
5
Cell-free and Concentrated Ascites Reinfusion Therapy for Refractory Ascites in Cirrhosis in Post-marketing Surveillance and the Role of Tolvaptan.上市后监测中肝硬化难治性腹水的无细胞浓缩腹水回输疗法及托伐普坦的作用
Intern Med. 2019 Nov 1;58(21):3069-3075. doi: 10.2169/internalmedicine.3091-19. Epub 2019 Jul 10.
6
Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites.快速通道随机对照试验评估无细胞浓缩腹水回输疗法治疗难治性恶性腹水患者的可行性。
BMC Cancer. 2022 Feb 28;22(1):218. doi: 10.1186/s12885-022-09336-3.
7
Changes in Coagulation and Fibrinolytic Factors in Patients With Cirrhotic Refractory Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy: A Retrospective Observational Study in Japan.日本一项回顾性观察研究:无细胞浓缩腹水回输治疗肝硬化难治性腹水患者凝血和纤溶因子的变化。
In Vivo. 2023 May-Jun;37(3):1226-1235. doi: 10.21873/invivo.13199.
8
Relationship among volume of paracentesis, portal blood flow and renal resistive index, evaluated by duplex Doppler ultrasonography in cirrhosis with tense ascites.
Recenti Prog Med. 1996 Apr;87(4):164-6.
9
Doppler hemodynamic study in portal hypertension and hepatic encephalopathy.门静脉高压症和肝性脑病的多普勒血流动力学研究
Hepatogastroenterology. 2005 Jan-Feb;52(61):156-60.
10
Management of Refractory Ascites for Liver Transplant Candidates: A Novel Cell-free and Concentrated Ascites Reinfusion Therapy.
Transplant Proc. 2019 Oct;51(8):2740-2744. doi: 10.1016/j.transproceed.2019.02.060.

本文引用的文献

1
Sequential hemodynamic changes for large volume paracentesis in post-hepatitic cirrhotic patients with massive ascites.肝炎后肝硬化大量腹水患者大量放腹水时的血流动力学序贯变化。
Proc Natl Sci Counc Repub China B. 1996 Oct;20(4):117-22.